NEW YORK (AP) -- Shares of AMAG Pharmaceuticals Inc. dropped to an annual low Wednesday as investors worried that a government panel will put up roadblocks to the approval of the company’s key drug candidate.
NEW YORK (AP) -- Shares of AMAG Pharmaceuticals Inc. dropped to an annual low Wednesday as investors worried that a government panel will put up roadblocks to the approval of the company’s key drug candidate.
